Immediate Impact
66 standout
Citing Papers
Exploring treatment options in cancer: tumor treatment strategies
2024 Standout
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update
2024 Standout
Works of E. Compérat being referenced
Risk tables for predicting progression using the 1973 and 2004/2016 WHO grading classification systems in primary Ta/T1 non-muscle invasive urothelial carcinoma of the bladder: A multicenter EAU NMIBC guidelines panel study
2020
Influence of pathological factors on oncological outcomes after robot-assisted radical prostatectomy for localized prostate cancer: Results of a prospective study
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| E. Compérat | 90 | 93 | 102 | 135 | 31 | 341 | |
| Soichiro Hasegawa | 82 | 38 | 45 | 51 | 34 | 334 | |
| José M. Ricart | 57 | 70 | 86 | 20 | 39 | 360 | |
| María L. Picazo | 43 | 100 | 148 | 32 | 26 | 357 | |
| Wendy Robson | 74 | 146 | 128 | 179 | 28 | 369 | |
| Anthony Pham | 82 | 188 | 67 | 54 | 26 | 324 | |
| Pridvi Kandagatla | 82 | 103 | 54 | 55 | 28 | 409 | |
| Andrew Adamson | 142 | 82 | 24 | 87 | 27 | 300 | |
| C Charpin | 63 | 25 | 135 | 35 | 26 | 394 | |
| Satoshi Maruyama | 121 | 154 | 47 | 52 | 36 | 357 | |
| Abdelhafeez H. Abdelhafeez | 206 | 91 | 63 | 66 | 27 | 318 |
All Works
Loading papers...